Myogen's P2P Acquisition

Myogen raised a round of funding on October 02, 2006. Investors include Gilead Sciences.

Myogen is engaged in the discovery and development of drugs for the treatment of heart failure and related cardiovascular conditions.…

Articles about Myogen's P2P Acquisition: